Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2017 May;23(5):812. doi: 10.3201/eid2305.ET2305

Etymologia: Fluoroquinolone

Ronne Henry
PMCID: PMC5403039

Fluoroquinolone [floorʺo-kwinʹo-lōn]

The first quinolone (quinol[ine] + -one [compound related to ketone]), nalidixic acid (Figure), was isolated as a byproduct of chloroquine (see “quinine”) synthesis and was introduced in 1962 to treat urinary tract infections. In 1980, researchers at the Kyorin Pharmaceutical Company showed that the addition of a fluorine atom to the quinolone ring resulted in an antibiotic with broader antimicrobial activity, which was named norfloxacin, the first fluoroquinolone. In 1983, Bayer published data that showed adding a single carbon atom to norfloxacin—what would become ciprofloxacin—further increased activity. Fluoroquinolones are today among the most frequently used antimicrobial drugs to treat infections in humans and animals.

Figure.

Figure

By Reubot, Public domain, Wikimedia Commons, https://commons.wikimedia.org/w/index.php?curid=14746558

Footnotes

Suggested citation for this article: Etymologia: Fluoroquinolone. Emerg Infect Dis 2017 May [date cited]. http://dx.doi.org/10.3201/eid2305.ET2305

Sources

  • 1.Dorland’s Illustrated Medical Dictionary. 32nd ed. Philadelphia: Elsevier Saunders; 2012. [Google Scholar]
  • 2.Ito A, Hirai K, Inoue M, Koga H, Suzue S, Irikura T, et al. In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother. 1980;17:103–8. 10.1128/AAC.17.2.103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Petri WA Jr. Sulfonamides, trimethoprim–sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Brunton LL, editor. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw Hill; 2011. p. 1463–76. [Google Scholar]
  • 4.Wise R, Andrews JM, Edwards LJ. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983;23:559–64. 10.1128/AAC.23.4.559 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES